Studies of hearing aids in people
17 studies gave hearing aids to people and measured what changed
| What changed | Design | People | Source |
|---|---|---|---|
no change: Has no effect on dementiaRR, 0.59; 95% CI, 0.25-1.38 up: Improves cognitive functionRR, 5.94; 95% CI, 2.46-14.37 | Randomized trial24-month | 703 peopleBothmean 74.53 years, range 60-96 yearsOlder adults with MCI | JAMA neurology, Sep 28, 2026 |
down: Decreases GFAPdifference: −0.175; 95% CI: −0.322, −0.028 no change: Has no effect on NfLdifference: −0.159; 95% CI: −0.348, 0.029 | Randomized trial3 years | 977 peopleBoth70–84 yearsCommunity-dwelling older adults | EClinicalMedicine, Sep 3, 2026 |
down: Decreases glial fibrillary acidic proteinmean -0.415 (95% CI -0.712, -0.118) down: Decreases NfLmean -0.349 (95% CI -0.652, -0.046) no change: Has no effect on neurodegeneration blood biomarkers | Randomized trial3 years | 164 people70–84 yearsOlder adults; in ARIC participants with untreated hearing loss | GSA 2025 abstract, Dec 31, 2025 |
no change: Has no effect on functional limitations no change: Has no effect on activities of daily living no change: Has no effect on instrumental activities of daily living | Randomized trial3 years | 977 peopleolder adultsOlder adults | GSA 2025 abstract, Dec 31, 2025 |
| Trial12 months | 28 peopleBothmean age=77.4 yearsOlder adults; early compared to late hearing aid intervention | AAIC 2025 abstract, Dec 25, 2025 | |
down: Decreases fallsmean difference −0·54 (95% CI −0·77 to −0·31), 27% reduction | Randomized trial3 years | 977 people523 (54%) participants were female and 454 (46%) were male76·8 years (SD 4·0)Older adults with untreated hearing loss | The Lancet. Public health, May 30, 2025 |
down: Decreases cognitive decline61.6% reduction (95% CI: 33.7%–94.1%) | Randomized trialmedian follow-up time was 3.1 years (3.0, 3.2) | 977 people53.5% female76.8 yearsOlder adults with hearing loss and without cognitive impairment | Alzheimer's & dementia : the journal of the Alzheimer's Association, May 1, 2025 |
up: Improves cognitive function down: Decreases NfL | Trialsix months | 50 peopleolder adultsPatients with age-related hearing loss and age- and sex-matched healthy controls | Journal of clinical medicine, Jan 21, 2025 |
no change: Has no effect on short Physical Performance Batteryβ=-0.001; 95%CI: -0.115, 0.113; p-value: 0.98 no change: Has no effect on grip strengthβ=0.016; 95%CI: -0.054, 0.085; p-value: 0.66 | Randomized trial3-year | 977 peopleBothmean age of 76.8±4.0 yearsOlder adults | GSA 2024 abstract, Dec 31, 2024 |
up: Improves speech-in-noise performancebaseline 19.0 (16.0-22.5) to 21.3 at 2 months and 20.0 at 3 years | Randomized trial3-years | 220 peopleBothmedian age=75.5Older adults; Patient cohorts | GSA 2024 abstract, Dec 31, 2024 |
| Randomized trial3 years | 445 peopleBoth70-84 yearsOlder adults; untreated hearing loss | GSA 2024 abstract, Dec 31, 2024 | |
up: Improves hearing Handicap Inventory-Elderly Screening version score | Randomized trial3 years | 923 people53.0% were femalemean age was 76.7 years (standard deviation (SD) = 4.0)Participants aged 70-84 years with adult-onset bilateral hearing loss, no current hearing aid use, and no substantial cognitive impairment | Journal of the American Geriatrics Society, Sep 12, 2024 |
no change: Has no effect on cognitive functionDifference 0·002 [95% CI: −0·077, 0·081] down: Decreases cognitive decline-48%, Difference 0·191 [95% CI: 0·022, 0·360] no change: Has no effect on cognitive impairmentHR 0·90 [95% CI: 0·61, 1·33] | Randomized trial3-year | 977 people53.5% femalemean age of 76·8 years (SD 4·0)Older adults aged 70 to 84 years with adult-onset bilateral hearing loss and free of substantial cognitive impairment | Lancet (London, England), Jul 18, 2023 |
down: Decreases Hearing Handicap Inventory for the Elderlyactive −12.47 vs. sham −4.19, ES=1.05 no change: Has no effect on depressionactive −5.50 vs. sham - 7.32, ES=0.38 up: Improves cognitive functionactive +14.9 vs. sham +5.7, ES=0.62 | Randomized trial12-week | 25 peopleaged ≥60 yearsOlder adults with comorbid HL and MDD | The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry, Aug 14, 2021 |
up: Improves hearing functioningnp-ES = 0.62 up: Improves cognitive functionnp-ES = 0.25 up: Improves general functioningnp-ES = 0.53 | Randomized trial12 weeks | 13 people≥60 yearsOlder adults; depressed older adults with age-related hearing loss | International journal of geriatric psychiatry, Apr 16, 2020 |
up: Increases cortical auditory evoked potentials | Trialsix months | older adultsOlder adults; first-time hearing aid users with age-related hearing loss, compared with hearing-matched controls | Neuropsychologia, May 2, 2018 |
up: Improves gait velocity20.5 cm/s higher gait velocity; five-point better Mini-BESTest score | Trial | 3 peopleadultMénière's disease; aided versus unaided condition | Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology, Feb 10, 2017 |